Bemcentinib

(Synonyms: R428; BGB324)
63 Cited Publications
Revisión del cliente

Based on 63 publication(s) in Google Scholar

Bemcentinib (R428) is a selective and orally active Axl inhibitor with an IC50 of 14 nM. Bemcentinib retards cancer cell migration and invasion. Bemcentinib exhibits >100-fold selectivity for Axl versus Abl and 50- and >100-fold selectivity over TAM family kinases Mer and Tyro3, respectively, in cells. Bemcentinib blocks tumor spread and prolongs survival in models of metastatic breast cancer.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.92%
  • No. CAS: 1037624-75-1
  • Fòrmula: C30H34N8
  • Peso molecular:506.64
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Bemcentinib

More
Customer Validation & Images
WB
  • WB
  • WB
  • WB
  • WB
  • WB
  • WB

Ver todos los productos específicos de isoformas TAM Receptor

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00